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Abstract
Background: The pandemic by the novel H1N1 virus has created the need to study any probable effects of that infection in
the immune system of the host.
Methodology/Principal Findings: Blood was sampled within the first two days of the presentation of signs of infection from
10 healthy volunteers; from 18 cases of flu-like syndrome; and from 31 cases of infection by H1N1 confirmed by reverse RT-
PCR. Absolute counts of subtypes of monocytes and of lymphocytes were determined after staining with monoclonal
antibodies and analysis by flow cytometry. Peripheral blood mononuclear cells (PBMCs) were isolated from patients and
stimulated with various bacterial stimuli. Concentrations of tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-18,
interferon (FN)-alpha and of IFN-gamma were estimated in supernatants by an enzyme immunoassay. Infection by H1N1
was accompanied by an increase of monocytes. PBMCs of patients evoked strong cytokine production after stimulation with
most of bacterial stimuli. Defective cytokine responses were shown in response to stimulation with phytohemagglutin and
with heat-killed Streptococcus pneumoniae. Adaptive immune responses of H1N1-infected patients were characterized by
decreases of CD4-lymphocytes and of B-lymphocytes and by increase of T-regulatory lymphocytes (Tregs).
Conclusions/Significance: Infection by the H1N1 virus is accompanied by a characteristic impairment of the innate immune
responses characterized by defective cytokine responses to S.pneumoniae. Alterations of the adaptive immune responses
are predominated by increase of Tregs. These findings signify a predisposition for pneumococcal infections after infection
by H1N1 influenza.
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Introduction
Our world is facing the pandemic of influenza H1N1 viral
infection with probable immense effects on daily lives and on the
world economy due to the easiness of transmission and to the high
virulence of the virus [1,2]. As of August 30
th, world health
organization (WHO) has reported 254206 laboratory-confirmed
cases of infection of H1N1 infection; as of August 2
nd 26513 of
these cases have occurred in the European continent [3,4]. These
data are considered to be an under-estimation of the situation
occurring worldwide due to the existence of cases with a very mild
physical course not seeking medical attention. However, a total of
2837 deaths have been reported from the confirmed cases.
The main question that needs to be answered when taking care of
a severely ill patient infected by the H1N1 virus is if deterioration of
the human host is due to the virus per se or to impairment of the
immune system created in the field of infection and to any subsequent
predilection for super-infections. Data to provide a clear-cut answer
are missing. The present study is aiming to evaluate if infection by the
novel H1N1 virus may lead to impairment of the function of the
innate and adaptive immune responses of the human host.
Results
Demographic Characteristics
A total of 110 patients were screened; 59 were enrolled in the
study. Thirty-one patients were infected by H1N1 virus and six
developed H1N1-related pneumonia; their mean 6 SD age was
28.5611.6 years; 17 were male and 14 female. Fever and malaise
were the predominant symptoms occurring in all patients (100%)
followed by cough in seven (22.5%) patients; and diarrhea in
three patients (9.8%). Mean 6 SD white blood cells were
5708.062578.8/ml. No underlying medical history was reported
in any patient. Infection convalescence was noted in all.
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mean 6 age was 39.6615.2 years; 10 were male and eight female.
Fever and malaise were the predominant symptoms occurring in
all patients (100%) followed by cough in six (31.6%) patients;
and diarrhea in three patients (15.8%). Mean 6 SD white blood
cells were 8722.264817.3/ml. No underlying medical history
was reported in any patient. None of these patients developed
pneumonia. Infection convalescence was noted in all.
Mean 6 SD age of healthy volunteers was 36.367.4 years.
Mean 6 SD white blood cells were 5170.061296.2/ml.
Effects in the Innate Immune System
Infection by the H1N1 virus was accompanied by significant
increase of monocytes (p,0.0001 compared with healthy
volunteers). Co-expression of HLA-DR on monocytes was more
than 96% in all patients (Figure 1)
Mean rates of apoptosis of monocytes were 52.4%, 65.5% and
75.5% among healthy volunteers, among patients with flu-like
syndrome and among patients infected by the H1N1 virus
respectively (p non-significant between groups). Respective mean
rates of apoptosis of NKT-cells were 16.6%, 34.3% and 39.1%
(p non-significant between groups). Respective mean rates of
apoptosis of NK-cells were 19.1%, 27.2% and 23.1% (p non-
significant between groups).
Concentrations of TNFa of PBMCs-stimulated supernatants are
shown in Figure 2. Patients infected by the H1N1 virus had lower
production of TNFa after stimulation with PHA (p,0.0001
compared with healthy volunteers) and heat-killed PSSP (p,0.0001
compared with healthy volunteers).
Concentrations of IL-1b of PBMCs-stimulated supernatants are
shown in Figure 3. No differences were found between healthy
volunteers, patients with flu-like syndrome and patients infected by
the H1N1 virus.
In order to define if the effect of H1N1 is related with the
production of TH-1 type cytokines or not, concentrations of IL-6,
IL-18, IFNa and IFNc were also estimated in supernatants of
PBMCs stimulated with either PHA or Streptococcus pneumoniae
(Figure 4). It was found that stimulation of PBMCs of both
patients with flu-like syndrome and H1N1-infection produced
greater concentrations of IL-6 compared with healthy volunteers
(p: 0.009 for comparisons between flu-like syndrome and healthy
volunteers; p: 0.009 for comparisons between H1N1 infection
Figure 1. Absolute counts of monocytes, of natural killer T-cell (NKT) and of natural killer (NK) cells. Results refer to 10 healthy
volunteers, 18 patients with flu-like syndrome and 31 patients infected by the H1N1 virus. Expression of HLA-DR on monocytes is also shown. a:
denotes statistically significant differences compared with healthy volunteers; b: denotes statistically significant differences compared with patients
with a flu-like syndrome.
doi:10.1371/journal.pone.0008393.g001
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IL-18 and IFNa were below the lower detection limit. Production
of IFNc was greater by PBMCs of H1N1-infected patients after
stimulation either with PHA (p: 0.010 compared with healthy
volunteers) or with S.pneumoniae (p: 0.029 compared with healthy
volunteers).
Effects in the Adaptive Immune System
Infection by the H1N1 virus was accompanied by significant
decrease of CD4-lymphocyte counts (p: 0.003 compared with
healthy volunteers) and of B-lymphocyte counts (p,0.0001
compared with healthy volunteers). A significant increase of Tregs
was also found compared with healthy volunteers (p: 0.001)
(Figure 5).
Mean rates of apoptosis of CD4-lymphocytes were 9.94%,
17.7% and 11.2% among healthy volunteers, among patients with
flu-like syndrome and among patients infected by the H1N1 virus
respectively (p non-significant between groups). Respective mean
rates of apoptosis of B-lymphocytes were 16.2%, 18.4% and
17.3% (p non-significant between groups). Respective mean rates
of apoptosis of CD8-lymphocytes were 36.9%, 44.1% and 39.3%
(p non-significant between groups).
Comparisons between H1N1-Infected Patients without
and with Pneumonia
Any of the above estimated parameters of the innate and
adaptive immune systems were compared between 25 H1N1-
infected patients without pneumonia and six patients with H1N1-
related pneumonia. No differences were found between them with
the sole exception of Tregs counts being greater among the latter
compared with the former (p,0.0001) (Figure 6).
Serum Cytokines
Concentrations of TNFa and IL-1b in serum did not differ
between the three groups. Those of IL-6 were higher in serum of
patients with flu-like syndrome compared with healthy volunteers
(p: 0.025) and in patients with H1N1 infection compared with
healthy volunteers (p: 0.034) (Figure 7).
Over-Time Changes
Absolute counts of monocytes and of B-lymphocytes of patients
infected by the H1N1 virus at baseline and after 48 hours are
shown in Figure 8. Counts of monocytes did not change; however
absolute counts of B-lymphocytes were increased (p: 0.034
compared with baseline).
Figure 2. Production of tumour necrosis factor-alpha (TNFa). Peripheral blood mononuclear cells of 10 healthy volunteers, of 18 patients with
flu-like syndrome and of 31 patients infected by the H1N1 virus were stimulated with endotoxins (LPS), phytohemagglutin (PHA), and heat-killed
isolates of Candida albicans,o fPseudomonas aeruginosa, of methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin (MRSA-
PVL) and of penicillin-susceptible Streptococcus pneumoniae. Superscript ‘‘a’’ denotes statistically significant differences compared with healthy
volunteers; superscript ‘‘b’’ denotes statistically significant differences compared with patients with flu-like syndrome.
doi:10.1371/journal.pone.0008393.g002
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The emerging flu pandemic by the H1N1 virus creates
considerable dilemmas in all health-care authorities about the
real threat for the human host. It is traditionally been conceived
that danger to the host is created when infection by an influenza
type A strain predisposes to secondary infections by bacterial
pathogens [2]. Estimation of that danger for the public health
requires in-depth knowledge of the effects of the emerging H1N1
virus in the innate and adaptive immune responses of the host. To
fully elucidate this, immune responses of laboratory-confirmed
cases were studied and compared with those of healthy volunteers
and those of patients with flu-like syndrome who were negative for
infection by H1N1.
Results revealed that within the first two days of advent of the
first symptoms, considerable changes of both the innate and the
adaptive immune responses were found among patients infected
by the H1N1 virus. Principal changes were a) increase of absolute
monocyte counts; b) selective defect of TNFa and IFNc
production from PBMCs after stimulation with S.pneumoniae; and
c) increase of absolute counts of Tregs mainly observed among
patients with H1N1-related pneumonia.
Despite the increase of absolute monocyte counts, the
expression of HLA-DR on monocytes remained very high. This
is of considerable importance for the effect of H1N1 infection on
our immune system. High level of expression of HLA-DR on
monocytes is an index of the ability of the innate immune system
for antigen-presentation. Suppression of the expression of HLA-
DR on monocytes is characteristic of immunoparalysis that
supervenes in moribund conditions like sepsis and that creates
predisposition for super-infection by a variety of pathogens [5].
This does not seem to happen in the event of infection by H1N1
influenza.
To fully clarify the effect of infection by H1N1 on the monocyte
function, PBMCs of H1N1-infected patients were stimulated with
a variety of stimuli representative of a broad range of pathogens
like Gram-negative bacteria, Gram-positive cocci and fungi.
Production of cytokines was adequate for most of the applied
stimuli being similar to that of healthy volunteers. Pro-inflamma-
tory cytokines were also estimated in serum of patients. IL-6 was
increased in both patients with flu-like syndrome and patients with
H1N1 infection. In an earlier study of 39 patients with either
influenza A or B in Hong Kong during the first semester of 2006
i.e. well before the arrival of H1N1, concentrations of pro-
inflammatory cytokines were estimated in plasma and found
particularly elevated [6].
Defective cytokines responses were noted after stimulation of
PBMCs with PHA and with S.pneumoniae and involved production
Figure 3. Production of interleukin-1beta (IL-1b). Peripheral blood mononuclear cells of 10 healthy volunteers, of 18 patients with flu-like
syndrome and of 31 patients infected by the H1N1 virus were stimulated with endotoxins (LPS), phytohemagglutin (PHA), and heat-killed isolates of
Candida albicans,o fPseudomonas aeruginosa, of methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin (MRSA-PVL) and
of penicillin-susceptible Streptococcus pneumoniae.
doi:10.1371/journal.pone.0008393.g003
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This implies that infection by H1N1 creates a selective impairment
of the innate immune response for S.pneumoniae probably mediated
through the TH1 immune response.
Infection by H1N1 was also accompanied by alterations of the
adaptive immune responses. Decreases of CD4-lymphocytes and
of B-lymphocytes and increase of Tregs were observed. The
former decreases occurred not only in H1N1-infected patients but
also in enrolled patients with flu-like syndrome. Apoptosis was not
a mechanism involved in the induction of these changes. However,
increase of the absolute count of Tregs was a predominant finding
of H1N1 infection particularly when infection involved the lower
respiratory tract. This may be a sign of an attempt of the host to
counterbalance exaggerated immune responses since Tregs are
acting by enhancing endogenous anti-inflammatory responses [7].
B-lymphocytes also started to increase within the first 48 hours
after baseline counting. This is a very optimistic sign for the impact
of H1N1 infection on our health since B-lymphocytes are
responsible for antibody production.
However several limitations of this study should be addressed.
Viral load of H1N1 and probable correlations with the described
immune alterations were not assessed. It should also be
underscored that the study was focused on circulatory effector
cells whereas potent immune cells may be accumulated in the
infection site. Even if this is the case, the validity of the study
remains intact since results describe a qualitative derangement of
circulatory effector cells within the first 48 hours of initiation of
symptoms of infection by the new H1N1 virus.
The presented results revealed that infection by the H1N1 virus
is accompanied by a characteristic impairment of the innate
immune responses characterized by defective cytokine responses to
S.pneumoniae. This is accompanied by alterations of the adaptive
immune responses predominated by increase of Tregs. The
significance of the presented results is underscored by three key-
elements: a) alterations of the immune responses are shown even
with a study enrolling a relative few number of patients; b) H1N1-
infected cases are either of moderate severity or of considerable
severity since they are all presented with fever above 38.5uC
whereas pneumonia is presented in six; and c) enrolled patients
infected by H1N1 influenza are young of a mean age of 28.4 years
without any underlying disease. It may be postulated that since
impairments of the immune responses for S.pneumoniae are even
seen for young infected patients, these findings have considerable
value for patients with underlying diseases predisposing to
pneumococcal infections. It should be further underscored that
reported cases of severe infection by the H1N1 virus accompanied
by pneumonia and increased mortality were between 15 and 44
years old [8,9] i.e. within the age range of patients enrolled in the
Figure 4. Cytokine production by peripheral blood mononuclear cells of healthy volunteers, of patients with flu-like syndrome and
of patients infected by the H1N1. a) interleukin-6 (IL-6) after stimulation with one heat-killed isolate of penicillin-susceptible Streptococcus
pneumoniae; b) IL-18 after stimulation with one heat-killed isolate of penicillin-susceptible Streptococcus pneumoniae; c) interferon-alpha (IFNa) after
stimulation with one heat-killed isolate of penicillin-susceptible Streptococcus pneumoniae; d) interferon-gamma (IFNc) after stimulation with
phytohemagglutin (PHA); and e) IFNc after stimulation with one heat-killed isolate of penicillin-susceptible Streptococcus pneumoniae. Superscript ‘‘a’’
denotes significant differences compared with healthy volunteers.
doi:10.1371/journal.pone.0008393.g004
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to better understand the life cycle of H1N1 in the human host and
to improve our strategies to control it.
Methods
Ethics Statement
The study was performed during the period July-August 2009.
The study protocol was approved by the Ethics Committee of the
ATTIKON University Hospital of Athens. All patients admitted in
the emergency department for flu-like symptoms and who
provided written-informed consent were eligible. Only patients
with core temperature greater than 38.5uC were further screened
for enrolment.
Study Design
Inclusion criteria were: a) written informed consent; b) age more
or equal to 16 years; c) symptoms compatible with infection by
H1N1 as already defined [10]; d) core temperature above 38.5uC;
and e) start of symptoms within the last two days. Exclusion
criteria were: a) deny to consent; b) known infection by the human
immunodeficiency virus (HIV); c) neutropenia defined as an
Figure 5. Absolute counts of CD4-lymphocytes, of CD8-lymphocytes, of T-regulatory cells and of B-lymphocytes. Results refer to 10
healthy volunteers, 18 patients with flu-like syndrome and 31 patients infected by the H1N1 virus. a: denotes statistically significant differences
compared with healthy volunteers; b: denotes statistically significant differences compared with patients with flu-like syndrome.
doi:10.1371/journal.pone.0008393.g005
Figure 6. Absolute counts of T-regulatory cells of patients
infected with the H1N1 virus. Results are given separately for 25
patients without pneumonia and for six patients with pneumonia
(p,0.0001).
doi:10.1371/journal.pone.0008393.g006
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PLoS ONE | www.plosone.org 6 December 2009 | Volume 4 | Issue 12 | e8393Figure 7. Serum levels of tumour necrosis factor-alpha (TNFa), of interleukin-1beta (IL-1b) and of IL-6. Results refer to 10 healthy
volunteers, 18 patients with flu-like syndrome and 31 patients infected by the H1N1 virus enrolled in the study. Superscript ‘‘a’’ denotes significant
differences compared with healthy volunteers.
doi:10.1371/journal.pone.0008393.g007
Figure 8. Absolute counts of monocytes and B-lymphocytes. Results refer to 31 patients infected by the H1N1 virus at baseline and after
48 hours. P values denote statistically significant differences between the two time points.
doi:10.1371/journal.pone.0008393.g008
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microliter (ml) of blood; d) oral intake of corticoids defined as more
than 1 mg/kg of body weight of equivalent prednisone for more
than one month.
Enrolled patients underwent a detailed work-out comprising
case-history and epidemiological history, thorough physical
examination, chest X-ray if considered necessary, white blood
cell count, and urine analysis for detection of leukocytes and
nitrate and detection of antigens of Streptococcus pneumoniae and of
Legionella pneumophila. If the above work-out failed to disclose the
presence of bacterial infection, a pharyngeal smear was collected
with a swab. Infection by the H1N1 virus was diagnosed by the
real-time reverse transcriptase polymerase chain reaction detecting
the presence of H1N1 RNA in the infected cells (rRT-PCR) [11].
A patient was considered to present with a lower respiratory tract
infection (LRTI) due H1N1 virus when a local infiltrate was
diagnosed in chest X-ray and H1N1 RNA was detected in
the pharyngeal swab, as defined elsewhere [8,9]. Patients were
followed-up until complete resolution of symptoms.
In parallel with the collection of the pharyngeal smear, 25
milliliters of whole blood were collected after venipuncture of one
forearm antecubital vein under sterile conditions. Twenty ml
blood were collected into two EDTA-coated tubes (Vacutainer,
Becton Dickinson, Cockeysville Md) and another 5 were collected
into sterile and pyrogen-free tubes (Vacutainer) and transferred
immediately to the laboratory for further analysis. Blood was also
sampled from 10 healthy volunteers.
For patients diagnosed with H1N1 infection, 5 ml of blood was
also sampled after 48 hours as described above.
Laboratory Procedure
In whole blood collected into the first tube, red blood cells were
lyzed with ammonium chloride 1.0 mM. White blood cells were
washed three times with phosphate buffered saline (PBS, pH 7.2)
(Merck, Darmstadt, Germany) and subsequently incubated for 15
minutes in the dark with the monoclonal antibodies anti-CD3,
anti-CD4, anti-CD14 and anti-CD19 and the protein ANNEXIN-
V at the flurochrome fluorescein isothiocyanate (FITC, emission
525 nm, Immunotech, Marseille, France); with the monoclonal
antibodies anti-CD4, anti-CD8, anti-CD14, anti-CD(16+56), anti-
CD25 and anti-HLA-DR at the fluorochrome phycoerythrin (PE,
emission 575 nm, Immunotech); with the monoclonal antibody
anti-CD3 and anti-CD127 at the fluorochrome ECD (emission
613 nm, Immunotech); with the monoclonal antibody anti-CD45
at the fluorochrome PC5 (emission 650 nm, Immunotech); and
with 7-AAD at the fluorocolour PC7 (emission 670 nm,
Immunotech). Fluorospheres (Immunotech) were used for the
determination of absolute counts. The following combinations
were studied: anti-CD3/anti-CD4/anti-CD45 for CD4-lympho-
cytes; anti-CD3/anti-CD8/anti-CD45 for CD8-lymphocytes;
anti-CD3/anti-CD(16+56)/anti-CD45 for Natural Killer (NK)-
cells and for NKT-cells; anti-CD4-/anti-CD25/anti-CD127/anti-
CD45 for T-regulatory cells (Tregs); anti-CD19/anti-CD45 for B-
lymphocytes; anti-CD14/anti-HLA-DR/anti-CD45 for immuno-
paralysis of monocytes; ANNEXIN-V/anti-CD4/anti-CD3/7-
AAD for apoptosis of CD4-lymphocytes; ANNEXIN-V/anti-
CD8/anti-CD3 for apoptosis of CD8-lymphocytes; ANNEXIN-
V/antiCD14/7-AAD for apoptosis of monocytes; ANNEXIN-V/
anti-CD19/7-AAD for apoptosis of B-lymphocytes. Cells were
analyzed after running through the EPICS XL/MSL flow
cytometer (Beckman Coulter Co, Miami, Florida) with gating for
lymphocytes or monocytes based on their characteristic FS/SS
scattering. Cells staining negative for CD3 and positive for
CD(16+56) were considered NK-cells; those staining positive for
both CD3 and CD(16+56) were considered NKT- cells. Cells
staining positive for both CD4 and CD25 and negative for CD127
were considered Tregs, according to other authors [12,13]. In all
analyzed cell subtypes, apoptotic cells stained positive for
ANNEXIN-V and negative for 7-AAD. Isotypic IgG controls
were used for each patient.
To verify the appropriateness to discriminate cells staining
positive for both CD4 and CD25 and negative for CD127 as
Tregs, blood sampling was repeated for seven newly enrolled
patients; two healthy volunteers, two patients with flu-like
syndrome and three patients with H1N1 infection. Absolute
counts of Tregs were estimated both as described above and with
the PE anti-human Foxp3 staining set (eBioscience Inc., San
Diego, USA). Median difference of the two assays was 5.88%.
Peripheral blood mononuclear cells (PBMCs) were isolated from
blood collected in the second tube after gradient centrifugation
over Ficoll (Biochrom, Berlin, Germany) for 20 minutes at 1400 g.
After three washings in ice-cold PBS pH 7.2, PBMCs were
counted in a Neubauer plate with trypan blue exclusion of dead
cells. They were then diluted in RPMI 1640 enriched with 2 mM
of L-glutamine, 500 mg/ml of gentamicin, 100 U/ml of penicillin
G and 10 mM of pyruvate (Biochrom) and suspended in wells of a
96-well plate. The final volume per well was 200 ml with a density
of 2610
6 cells/ml.
PBMCs were exposed in duplicate to the following stimuli for
24 hours at 37uCi n5 %C O 2: 10 ng/ml of Escherichia coli O55:B5
lipopolysaccharide (LPS, Sigma, St. Louis, USA); 5 mg/ml of
phytohemagglutin (PHA, EMC microcolecctions, Tu ¨bingen,
Germany); and 2610
5 colony forming units/ml of each of the
following heat-killed isolates: Candida albicans; Pseudomonas aeruginosa;
methicillin-resistant Staphylococcus aureus (MRSA) producing Pan-
ton-Valentine leukocidin (PVL); and penicillin-susceptible S.pneu-
moniae (PSSP). All the above were clinical isolates derived from the
blood of different patients with documented infections. Resistance
of S.aureus to methicillin and production of PVL were documented
by the detection of the mecA gene and the lucS-PV gene
respectively by PCR [14,15]. PSSP has been isolated from a
patient with LRTI and bacteremia and it has already been
described in a previous study [16].
Concentrations of tumour necrosis factor-alpha (TNFa) and of
interleukin-1beta (IL-1b) were estimated in cell supernatants in
duplicate by an enzyme immunoassay (R&D, Minneapolis, USA).
Those of interferon-gamma (IFNc) were estimated only in
supernatants of PHA-stimulated cells and of PSSP-stimulated cells
(Diaclone, Paris, France). Those of IL-6, of IL-18 and of IFNa
were estimated only in supernatants of PSSP-stimulated cells
(Diaclone, Paris, France and MBL, Nagoya, Japan). The lowest
detections limits were: for TNFa 80 pg/ml; for IL-1b 20 pg/ml;
for IL-6 60 pg/ml; for IL-18 130 pg/ml; for IFNa 40 pg/ml; and
for 100 IFNc pg/ml.
Blood collected into sterile and pyrogen-free tubes was
centrifuged and serum was stored at 270uC until assayed.
Concentrations of TNFa, IL-1b and IL-6 were estimated as
described above.
In blood samples collected 48 hours after the baseline, absolute
counts of monocytes and of B-lymphocytes were determined as
described above.
Statistical Analysis
Subjects were divided into healthy volunteers; into those
presenting with flu-like syndrome; and into those infected by the
H1N1 virus. Results were expressed as means 6 SE. Comparisons
between groups were compared by one-way analysis of variance
(ANOVA) with post-hoc Bonferroni analysis for the avoidance of
H1N1 and Immunity
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patients without and with pneumonia were done by Student’s
‘‘t-test’’. Comparisons between consecutive samplings were done
by paired ‘‘t-test’’. Any value of p below 0.05 was considered
significant.
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